Compounds > 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea
Page last updated: 2024-08-22

1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea and Recrudescence

1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea has been researched along with Recrudescence in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burger, PC; Byar, DP; Green, SB; Mahaley, MS; Malkin, MG; Pistenmaa, DA; Ransohoff, J; Shapiro, WR; Strike, TA; Vogel, FS1

Trials

1 trial(s) available for 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea and Recrudescence

ArticleYear
Superiority of PCNU over AZQ in the treatment of primary brain tumors: results of a prospective randomized trial (81-20) by the Brain Tumor Study Group.
    Journal of neuro-oncology, 1994, Volume: 22, Issue:1

    Topics: Antineoplastic Agents; Aziridines; Benzoquinones; Brain Neoplasms; Child; Humans; Middle Aged; Nitrosourea Compounds; Prospective Studies; Recurrence; Survival Analysis

1994